Watch the AllStripes, formerly RDMD, video session we did in 2020 to learn more about the Inclusion Body Myositis...
The primary focus of Myositis Support and Understanding is muscle diseases which are referred to as “Idiopathic Inflammatory Myopathies” or “Acquired Myopathies,” meaning muscle diseases which are typically not inherited and are caused by the immune system attacking muscles, connective tissue, blood vessels, and/or the skin.
An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for Sporadic Inclusion Body Myositis Video
, , Featured, Inclusion Body Myositis (IBM)
The ongoing Arimoclomol Clinical Trial for sIBM continues to generate a lot of questions from our community. As part...
The Performance of the EULAR/ACR IIM classification criteria in an expert-defined 10 year incident cohort
, , Featured, Myositis
This paper assesses the performance of EULAR/ACR classification criteria in a cohort of IIM cases and examines how subtypes...
An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for sIBM
, , Inclusion Body Myositis (IBM), Video
Watch "An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for sIBM" with Dr. Mazen Dimachkie,...
Identification of Predictors for Interstitial Lung Disease in Myositis Patients: A Systematic Review
, , Featured, Myositis, News
Interstitial lung disease (ILD) is a well-recognized complication in the spectrum of diseases known as the idiopathic inflammatory myopathies...
We are excited to announce a new collaboration with RDMD, a company that aims to jumpstart research for patients...
DETERMINE - a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults...
The first step when approaching a patient with muscle weakness – Differential diagnosis of idiopathic inflammatory myopathies in adults
, , Featured, Myositis
Information on the differential diagnosis of adults with muscle weakness. Differential diagnosis is the process of distinguishing a specific...
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis
, , Dermatomyositis, Featured, News
New locations announced July 9, 2019. DETERMINE is a double-blind, placebo-controlled 1-year study designed to test the efficacy and...
Myositis and Cancer: Risk highest for carriers of anti-TIF1 antibody
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
The authors propose that a new classification system for Idiopathic Inflammatory Myopathies (IIM) based on phenotypic (observable characteristics), biologic...
Advances in the Early Diagnosis and Therapy of Inclusion Body Myositis
, , Featured, Inclusion Body Myositis (IBM)
The purpose of this article is to describe advancements in the diagnosis of Inclusion Body Myositis (IBM) and therapy...
The information collected by ultrasound elastography (USE), such as structural changes of muscle, is thought to make it useful for...
Statin Use Associated with Idiopathic Inflammatory Myopathies
, , Featured, Necrotizing Autoimmune Myopathy
Statins are drugs that lower cholesterol. There have been reports indicating that statin use may be associated with idiopathic...
We would like to let you know about a clinical research study that is available for patients diagnosed with...
MSU’s guest author, Dr. Daniel Chellete, analyzed recent studies concerning exercise with Myositis. Dr. Chellete is a doctor of...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
New Insights on sporadic Inclusion body myositis (sIBM) pathogenesis
, , Inclusion Body Myositis (IBM), News, Video
Dr. Conrad "Chris" Weihl joins MSU live for a session titled "New Insights on sporadic Inclusion body myositis (sIBM)...
Watch "Polymyositis: The evolution of this diagnosis in light of recent research" with Dr. Christopher-Stine, who also discusses immune-mediated...
The NT5C1A Antibody Test and its Role in the Diagnosis of Inclusion Body Myositis
, , Inclusion Body Myositis (IBM), Video
Learn more about the NT5CIA antibody and its association with inclusion body myositis from Dr. Kevin Dooley, a retired...
